July 28, 2021 – Pfizer’s COVID-19 vaccine continues to show strong protection against serious illness and hospitalization after 6 months, but overall protection against the virus appears to wane after a half a year, according to a new study. The July 28, 2021, pre-print report of the study, which has not been peer-reviewed, suggests a… Read More »
THURSDAY, June 17, 2021 — The Pfizer and Moderna COVID vaccines pose no threat to male fertility, a finding experts hope will prompt more men to get vaccinated. Researchers noted that the original clinical trials of the two mRNA vaccines didn’t assess how they might affect fertility. “Vaccine hesitancy is a barrier to ending the… Read More »
With its trials and pricing set, Pfizer has pulled back the curtain on the long-range commercial strategy for its COVID-19 vaccine. During its earnings call Tuesday, execs laid out two phases, pandemic and seasonal, with some combination of the two likely to play out over the next several years. The current pandemic phase, expected to continue… Read More »
On the heels of early positive COVID-19 vaccine data, the CEOs at BioNTech and Pfizer are gearing up for a late-stage trial and talking up potential approvals later this year. In separate interviews this week, Pfizer CEO Albert Bourla and BioNTech CEO Ugur Sahin said their mRNA vaccine candidate could be ready to submit to regulators in the fall or winter, respectively, pending success in… Read More »